Clinical Research Management has been selected by the HHS' Biomedical Advanced Research and Development Authority
Clinical Research Management (ClinicalRM) has been selected by the HHS' Biomedical Advanced Research and Development Authority (BARDA) in its Medical Countermeasure Clinical Studies Network. That Network supports initiatives that help protect health against bioterrorism, pandemic influenza, and other public health emergencies. ClinicalRM is one of only 5 other companies to be awarded this contract. 100% of the total costs of the program will be financed with Federal money. It is a 2-year contract with three 1-years option BARDA may exercise. The total contract ceiling for 5-year program is $100 million. The Network supports initiatives that help protect health against bioterrorism, pandemic influenza and other public health emergencies.
